No amount of creativity or product superiority will be advantageous unless the pharmaceutical company is able to get its product to the market and into the hands of the end user. The selection of a productive sales and marketing team is critical to the survival of the company and this team must be adequately trained in not only the value and benefits of the product, but the techniques, initiatives and strategies necessary to go out into the marketplace and actually sell. Despite its importance, the effectiveness of the sales force is often given poor attention. Generally, pharmaceutical consultants have the desired levels of training to be able to motivate the company sales force, resulting in considerable financial gain due to elevated efficiency.

Have you ever heard of the saying, coined by a famous football coach – “winning isn’t everything, it’s the only thing!” Remember to keep this mindset engaged at all times. After all, a sale is either won or lost and a lost sale is of no value whatsoever, experience gained and contacts made notwithstanding.

It is essential to correctly motivate a team and one of the first things that a pharmaceutical consulting firm will help initiate is the creation of meaningful measurement tools. Within sales, the measurement of activity levels is only part of the equation. A sales executive is not necessarily highly efficient, even though his or her volume of sales may be high, as ultimate value must be assessed. The creation of the account must foster a value relationship between all the principals, quite apart from the raw dollar amounts involved. It is important to align the buyer’s strategy and position with the company’s. A correct level of incentive is very important and sales people must clearly understand that both the client and the company must achieve value before any deal is consummated.

Incentivisation requires the creation of meaningful benchmarks and goals. There must be a tangible carrot at the end of the road and achievable targets should lead to further incentives on a structured basis. If the sales executive is able to “get” to an end result, then he or she will not be adequately motivated to reach even further and keep working.

Time management is essential and while a sales manager will undoubtedly have administrative elements to take care of, the company should make sure that he or she is able to complete these as efficiently as possible, using provided, high-efficiency tools as needed. Did you know that many sales executives actually spend less than 25% of their time in direct communication with clients?

We can see that for the sales team to be effective, each member must be adequately trained and furthermore must engage in a process of ongoing training. This will include not only product education but also sales technique and delivery elements as well as time management and application theory, with the science of personal inter-communication. Bring in pharma consulting experts to get the mix right.

Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.

Proper incentivisation is critical to the effectiveness of an organisation’s sales force. This must be correctly approached however, as it is often poorly thought out or even bypassed, leading to lacklustre results, a reduction in morale and the inefficient use of a key resource. The pharmaceutical company may be a leader in its field, be very creative and with cutting-edge solutions, but the organisation will only be truly effective if its sales and marketing team is well prepared and trained. Such a team must be comprehensive, well balanced, able to employ different strategies and techniques and perform to a high-level of efficiency within a tough commercial field. Most pharmaceutical consultants have a wide range of experience themselves and know full well how to motivate, manage and process a sales team.

The achievement of the sale is not the end of the story. It is true to say that without sales nothing happens, but many different factors must be used to judge the absolute value of a sale. However efficient the executive, without the creation of a good relationship between both parties, the long-term baseline value of the transaction is questionable. In this analysis, incentives must be prepared and deployed selectively, with the aim of achieving a “win-win” solution all around.

Productivity generally increases if an individual is incentivised, as this is within our nature. Create sensible goals to move the sales force forward. Correct incentivisation will enhance the effectiveness of the sales force, but the opposite is also true. Rather than setting a goal, the incentive path should be a journey with multiple tiers and an endpoint that is always just out of reach. In this way, the sales executive will be always focused.

In most cases, pharmaceutical consulting firms tell us that sales executives spend the majority of their time on ancillary and sometimes mundane administrative work and a minority of their time in direct communication with prospects or engaged with client management. This is why time management should be considered as a top priority and company executives should never put onerous administrative and accounting burdens in front of their productive sales team. Creativity and enthusiasm can be stifled within certain outgoing personality types, through the imposition of onerous or even boring demands.

A sales force will only be really effective if a comprehensive training process is in place and the team member must feel that he or she is part of a dynamic organisation. Do not confuse administration with training – training is a priority, while administrative burdens should be minimised. This should include product awareness as well as methodology and techniques, and the latest procedures can be implemented through pharma consulting firms. These companies can bring a lot to the corporate table, using an extensive industry background, a variety of different perspectives, pep talks and rallies at just the right time to eliminate even the traces of negative emotions.

Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.

A pharmaceutical company that tries to operate at maximum efficiency while placing many constraints on the heads of its senior management may suffer in an ultra-competitive environment. The pharmaceutical and health-care fields are challenged like few others, as complex and often controversial forces are at play. The introduction of a new product is a long and very complex journey and once brought to creation is still a long way from being able to convert potential into sales, prompting many companies to bring in experienced pharmaceutical consulting experts.

These days, pharmaceutical consulting companies have to educate the company in the pressures ahead, as crucial products are designed for the consumer. Government regulations are stringent and development and manufacturing processes are such that senior executives of the organisation should devote their resources to these areas. Creation and production of cutting-edge pharmaceutical products are an important part of the health of the nation, yet further obstacles exist between production and ultimate distribution, obstacles that can seem overwhelming, especially if the company sometimes feels that it is “going it alone.”

Generally, pharmaceutical consultants will be entirely fluent in the language necessary to exist in this harsh marketing environment, and will play a critical role in helping the company’s sales force to succeed. Through comprehensive coaching, the sales and marketing team will come to learn what they can expect and take a lot of great information from the experienced consultant with relevant hands on knowledge. Consultants know that real world experience trumps paper qualifications. This type of experience will be passed through to the company sales force, placing them at a competitive advantage.

No matter how creative the pharmaceutical company may be, the acid test comes in sales and bottom line financial figures. Once regulators have approved a product and it is available for sale, the sales force must talk the correct language in front of insurers, physicians, pharmacists and decision-makers. Each one of these positions may have its own agenda and there are often complex cross party negotiations to consider. Without proper training, a sales and marketing force could stumble at the most inappropriate time and that is where a highly experienced pharma consulting firm will be worth its weight in gold.

Pharmaceutical and healthcare consulting firms must often be in the position of a middleman, fully aware of opposing arguments and able to position the marketing team correctly. It makes sense for the pharmaceutical company executives to enlist consultants to ensure that the company has the best chance of bringing all the hard work to market.

As healthcare is almost always a highly emotive and controversial subject, trust the experience and resources that consulting firms represent, to inform and enlighten the pharmaceutical company and motivate its sales and marketing staff to succeed. Scientific achievement and creation at one end is laudable, but without a first-class marketing team, success will be difficult to achieve.

Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.

In an increasingly sophisticated and competitive environment, pharmaceutical companies now realise that it is not sufficient to treat clients with a uniform approach and that certain client accounts represent an increased level of importance. This can be due to their position of dominance within the market, the volume of transactions or any other strategic elements making them of particular interest to the company. As such, key account management strategies must be implemented and communicated to the sales and marketing team as the company aims to cement relationships with these principles.

For the pharmaceutical company executives, client management can be as much about public relations, lobbying and positioning as it can be about the provision of products or services for the end need. While fundamentally the overall approach to client management must be decided at the executive level, implementation on a daily basis requires the effort of the sales and marketing team as the pharmaceutical consulting firm advises strategies and positions.

Success in the ultra-competitive business world requires attention to fine detail and a declaration of strategic importance for each account. The key accounts in turn will value the relationship with the pharmaceutical company more highly, especially if they are predisposed to a more interactive approach. The goal must be to facilitate the work of the key client and to ensure that the pharmaceutical company’s products are more widely available, at competitive rates and the subject of enhanced information and education.

Key account management can be broken down into five distinct areas:

Principally, the nature of the relationship must be agreed and understood by all parties. The exact nature of the relationship must be communicated throughout the company structure, so that an integrated response is always applicable. While formal communication is always important, including planning, reviews, development and information exchange, the goal must always be to strengthen the bond between the two companies.

Key account management must also help to build trust and commitment in both directions. The client must feel that it is in a comfort zone when dealing with the pharmaceutical company and will therefore not have to invest effort or money in trying to control certain activities associated with the program. As such, a level of efficiency is achieved that in turn helps to build even more commitment. This interaction may appear complex and daunting, but pharmaceutical consultants are well versed in such strategies.

When it comes to the sales and marketing team, the customer accounts must be fully reviewed, its content absorbed and potential understood. In truly key accounts, the pharmaceutical company will help the client through the dissemination of important trends and industry data. These accounts are always dynamic and a sales and marketing team must be on the ball and trained well.

Few relationships of this kind run smoothly and without issues from time to time. Conflicts are to be always avoided as they can create weaknesses in an association, but constructive conclusions should always be drawn as these could indeed lead to different paths and an even stronger relationship, down the road.

Key account management requires a continuous review of satisfaction. Any stumbling blocks ahead may be revealed and challenges will invariably be simpler to resolve, once they appear.

These five concepts are fundamental to the pharma consulting approach.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.